Dimensional Fund Advisors’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-61,247
Closed -$611 3525
2022
Q4
$611 Sell
61,247
-5,142
-8% -$38.3K ﹤0.01% 3004
2022
Q3
$366K Buy
66,389
+32,062
+93% +$178K ﹤0.01% 3112
2022
Q2
$125K Buy
+34,327
New +$162K ﹤0.01% 3305
2020
Q3
Sell
-58,714
Closed -$95K 3367
2020
Q2
$95K Sell
58,714
-63,830
-52% -$127K ﹤0.01% 3278
2020
Q1
$235K Hold
122,544
﹤0.01% 3183
2019
Q4
$349K Sell
122,544
-3,322
-3% -$9.62K ﹤0.01% 3188
2019
Q3
$419K Hold
125,866
﹤0.01% 3174
2019
Q2
$409K Buy
125,866
+2,749
+2% +$9.78K ﹤0.01% 3226
2019
Q1
$460K Hold
123,117
﹤0.01% 3178
2018
Q4
$425K Buy
123,117
+6,551
+6% +$32.3K ﹤0.01% 3170
2018
Q3
$836K Buy
116,566
+29,553
+34% +$230K ﹤0.01% 3101
2018
Q2
$607K Buy
87,013
+25,528
+42% +$159K ﹤0.01% 3095
2018
Q1
$378K Buy
+61,485
New +$387K ﹤0.01% 3146

Other funds holding APEN

Dimensional Fund Advisors's APEN Position: Q1 2023 in Review

Dimensional Fund Advisors sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 61,247 shares — an estimated $611 sold.

Dimensional Fund Advisors first reported a position in APEN in Q1 2018 and held it in 13 quarters. The position peaked at $836K in Q3 2018. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Dimensional Fund Advisors reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 61,247 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $611.
  • Dimensional Fund Advisors first reported a position in Apollo Endosurgery, Inc. in Q1 2018 and held it in 13 quarters.
  • Dimensional Fund Advisors's Apollo Endosurgery, Inc. position peaked at $836K in Q3 2018.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.